Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF ...
Lung cancer with MET exon 14 skipping mutation | LCTT
Frontiers | Case Report: A novel MET exon 14 skipping mutation after ...
Table 1 from The Unique Characteristics of MET Exon 14 Mutation in ...
Clinicopathological characteristics and MET exon 14 skipping mutation ...
MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer Iden
| Distribution of concurrent mutation detected in MET amplification and ...
A cancer-associated METTL14 mutation induces aberrant m6A modification ...
MET Exon 14 Mutation Encodes an Actionable Therapeutic Target in Lung ...
| NSCLC patients with MET amplification and METex14 skipping mutation ...
(PDF) Prevalence of MET exon 14 skipping mutation in pulmonary ...
Distinct MET Protein Localization Associated With MET Exon 14 Mutation ...
Full article: Detection of MET exon 14 skipping mutations in non-small ...
Capmatinib for patients with non-small cell lung cancer with MET exon ...
Diagnosis and Discussion -- Case 1068
Figure 1 from MET 14外显子跳跃突变在非小细胞肺癌中的研究进展 | Semantic Scholar
METex14 in non-small lung cancers. (a) schematic diagram of genomic ...
The pathogenesis of MET amplification and MET exon 14 alterations ...
Schematic representation of the effect of METex14 on MET stability and ...
Emerging Therapies and Testing for METex 14 in
The promise of selective MET inhibitors in non-small cell lung cancer ...
MET Exon 14 Skipping Activity. | Download Scientific Diagram
(PDF) Current and future treatment options for MET exon 14 skipping ...
MET exon 14 skipping and gain of function (GOF) mutations. (a ...
(PDF) Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung ...
MET Exon 14 Skipping Mutations in Non–Small-Cell Lung Cancer: An ...
Identification of a Novel MET Exon 14 Skipping Variant in Lung ...
MET Exon 14 Skipping Mutations in Lung Adenocarcinoma ...
MET receptor inhibition in solid tumors Roberto Bianco
MET exon 14 skipping alterations by site and regions of interest for ...
Intra-tumor and Inter-tumor Heterogeneity in MET Exon 14 Skipping ...
(PDF) MET exon 14 skipping mutations and gene amplification in a ...
Targeting un-MET needs in advanced non-small cell lung cancer - Lung Cancer
Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to ...
(PDF) Highly accurate DNA-based detection and treatment results of MET ...
Locations of MET exon 14 genomic alterations found in sarcomatoid ...
大咖说｜Paul Paik 教授谈 MET 14 外显子跳跃突变非小细胞肺癌（NSCLC）的治疗策略 - 知乎
Figure 1 from MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are ...
Mapping of MET exon 14 skipping mutations. The values indicate the ...
NSCLC 重大突破! 当 MET 遇见 MET 抑制剂 - 丁香园
MCE | 非小细胞肺癌与它的靶点 生物.医药.天然产物
What Is MET? - MET Crusaders
Identification of Novel MET Exon 14 Skipping Variants in Non-Small Cell ...
Highly accurate DNA-based detection and treatment results of MET exon ...
Durable Response to Crizotinib in a Patient with Pulmonary ...
MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With ...
| A novel MET exon 14 skipping variant concomitant MET amplification ...
Improvement of Diagnostics in NSCLC Patients with MET Exon 14 Mutations ...
MET exon 14 skipping alterations
Describes the normal MET signaling function (left) and pathogenic ...
MET Exon 14 Skipping in NSCLC | TEPMETKO® (tepotinib) HCP
Characterization of MET exon 14 alteration and association with ...
MET alterations in NSCLC—Current Perspectives and Future Challenges ...
MET Exon 14 Skipping Mutations in Lung Cancer: Clinical–Pathological ...
Full article: Novel Therapies for Metastatic Non-Small Cell Lung Cancer ...
Advances in clinical research of MET exon 14 skipping mutations in non ...
Frontiers | Recent advances in the treatment of non-small cell lung ...
The excellent response to crizotinib in some rare tumor with MET ...
Optimized Detection of Unknown MET Exon 14 Skipping Mutations in ...
Skipping or Not Skipping? That's the Question! An Algorithm to Classify ...
(PDF) Survival outcomes and prognostic factors of lung cancer patients ...
MET exon 14 skipping mutations in non-small-cell lung cancer a 3 years ...
MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations ...
Spectrum of MET mutations resulting in exon 14 skipping. | Download ...
Figure 1 from MET Exon 14 Alterations in Lung Cancer: Exon Skipping ...
Overview of Molecular Detection Technologies for MET in Lung Cancer
MET14跳跃突变治疗|外显子|肿瘤_新浪新闻
A phase II study of tepotinib in patients with advanced solid cancers ...
The Landscape of MET Exon 14 Skipping Mutations in Patients With Lung ...
ASCO 2020丨一项针对MET 14外显子跳跃突变肺癌患者的分析-肿瘤瞭望
c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon ...
Molecular Diagnostic Assays and Clinicopathologic Implications of MET ...
Current Therapeutic Landscape of MET exon 14 Skipping Mutations ...
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping ...
Identification of MET exon 14 skipping mutations in PSCs. (A) Schematic ...
Real-time PCR-based methods developed for MET exon 14D testing. Method ...
(PDF) Non-small cell lung cancer with MET exon 14 skip mutation: case ...
Responses to the Tepotinib in Gastric Cancers with MET Amplification or ...
High MET Overexpression Does Not Predict the presence of MET exon 14 ...
病理干货 | 系统汇总MET基因变异检测方法及靶向治疗-MedSci.cn
A) Overview of the 34 unique METex14del mutations detected by our NGS ...
MET Exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence ...
Frontiers | Case Report: A Lung Adenocarcinoma With Brain Metastasis ...
Schematic representation of MET variants. (A) Representation of novel ...
7 Awad MET Exon 14 Mutations in NSCLC JCO 2016 | PDF
Frontiers | Survival outcomes and prognostic factors of lung cancer ...
Acquired MET mutations after MET TKI in METex14 NSCLC, review of ...
Figure 1 from MET IHC is a Poor Screen for MET Amplification or MET ...
Retrospective Analysis to Optimize the Detection of MET Exon 14 ...
Advances in the diagnosis and treatment of MET-variant digestive tract ...
Response to MET Inhibitors in Patients with Stage IV Lung ...
(PDF) Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature ...
Cancer mutations rewire the RNA methylation specificity of METTL3 ...
MET∆14 promotes a ligand-dependent, AKT-driven invasive growth | Life ...
.jpg)
(233).jpg)
